Nothing Special   »   [go: up one dir, main page]

GB9714081D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB9714081D0
GB9714081D0 GBGB9714081.8A GB9714081A GB9714081D0 GB 9714081 D0 GB9714081 D0 GB 9714081D0 GB 9714081 A GB9714081 A GB 9714081A GB 9714081 D0 GB9714081 D0 GB 9714081D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9714081.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GBGB9714081.8A priority Critical patent/GB9714081D0/en
Priority to GBGB9718270.3A priority patent/GB9718270D0/en
Publication of GB9714081D0 publication Critical patent/GB9714081D0/en
Priority to UA99126573A priority patent/UA49955C2/en
Priority to PE1998000581A priority patent/PE84499A1/en
Priority to MYPI98002961A priority patent/MY119643A/en
Priority to HN1998000101A priority patent/HN1998000101A/en
Priority to DK98940152T priority patent/DK0999841T3/en
Priority to JP50638199A priority patent/JP3350061B2/en
Priority to DZ980159A priority patent/DZ2549A1/en
Priority to IDW991585A priority patent/ID24528A/en
Priority to AT98940152T priority patent/ATE206921T1/en
Priority to UY25078A priority patent/UY25078A1/en
Priority to PL98337803A priority patent/PL337803A1/en
Priority to PT98940152T priority patent/PT999841E/en
Priority to TNTNSN98126A priority patent/TNSN98126A1/en
Priority to AU88569/98A priority patent/AU724728B2/en
Priority to EA199901100A priority patent/EA002174B1/en
Priority to CA002292673A priority patent/CA2292673C/en
Priority to DE69802097T priority patent/DE69802097T2/en
Priority to HU0004468A priority patent/HUP0004468A3/en
Priority to MA25150A priority patent/MA26518A1/en
Priority to CNB988066289A priority patent/CN1145486C/en
Priority to ES98940152T priority patent/ES2163291T3/en
Priority to PCT/EP1998/004176 priority patent/WO1999001135A1/en
Priority to US09/402,239 priority patent/US6166025A/en
Priority to PA19988454501A priority patent/PA8454501A1/en
Priority to KR10-1999-7012523A priority patent/KR100384346B1/en
Priority to BR9810658-9A priority patent/BR9810658A/en
Priority to EP98940152A priority patent/EP0999841B1/en
Priority to NZ501419A priority patent/NZ501419A/en
Priority to ARP980103209A priority patent/AR013165A1/en
Priority to SI9830068T priority patent/SI0999841T1/xx
Priority to TR1999/03332T priority patent/TR199903332T2/en
Priority to IL13320698A priority patent/IL133206A0/en
Priority to SK1828-99A priority patent/SK284462B6/en
Priority to APAP/P/1998/001290A priority patent/AP1100A/en
Priority to ZA9805812A priority patent/ZA985812B/en
Priority to CO98037816A priority patent/CO4950555A1/en
Priority to GT199800105A priority patent/GT199800105A/en
Priority to IS5283A priority patent/IS5283A/en
Priority to BG103930A priority patent/BG103930A/en
Priority to NO19995887A priority patent/NO312993B1/en
Priority to OA9900271A priority patent/OA11227A/en
Priority to HR970276A priority patent/HRP990416B1/en
Priority to HK01100144A priority patent/HK1029282A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Packaging Of Annular Or Rod-Shaped Articles, Wearing Apparel, Cassettes, Or The Like (AREA)
GBGB9714081.8A 1997-07-03 1997-07-03 Pharmaceutical compositions Pending GB9714081D0 (en)

Priority Applications (45)

Application Number Priority Date Filing Date Title
GBGB9714081.8A GB9714081D0 (en) 1997-07-03 1997-07-03 Pharmaceutical compositions
GBGB9718270.3A GB9718270D0 (en) 1997-07-03 1997-08-28 Pharmaceutical compositions
UA99126573A UA49955C2 (en) 1997-07-03 1998-01-07 Aqueous pharmaceutical composition comprising eletriptan hemisulphate and caffeine
PE1998000581A PE84499A1 (en) 1997-07-03 1998-06-30 PHARMACEUTICAL COMPOSITIONS CONTAINING ELETRIPTAN HEMISULPHATE
MYPI98002961A MY119643A (en) 1997-07-03 1998-06-30 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
HN1998000101A HN1998000101A (en) 1997-07-03 1998-06-30 CUTTING LEAVES TO ASSEMBLE CIGARETTE PACKS
SK1828-99A SK284462B6 (en) 1997-07-03 1998-07-01 Aqueous pharmaceutical composition containing eletriptan hemisulphate and its use
ES98940152T ES2163291T3 (en) 1997-07-03 1998-07-01 PHARMACEUTICAL COMPOSITIONS CONTAINING ELETRIPTAN HEMISULFATE AND CAFFEINE.
PA19988454501A PA8454501A1 (en) 1997-07-03 1998-07-01 PHARMACEUTICAL COMPOSITIONS CONTAINING ELETRIPTAN HEMISULPHATE
DZ980159A DZ2549A1 (en) 1997-07-03 1998-07-01 Pharmaceutical compositions containing eletriptan hemisulfate.
IDW991585A ID24528A (en) 1997-07-03 1998-07-01 COMPOSITIONS OF PHARMACEUTICAL DRUGS CONTAINING HEMISULFATE AND CAFEIN ELECTRYPTANTS
AT98940152T ATE206921T1 (en) 1997-07-03 1998-07-01 PHARMACEUTICAL COMPOSITIONS CONTAINING ELETRIPTANHEMISULFATE AND CAFFEINE
UY25078A UY25078A1 (en) 1997-07-03 1998-07-01 PHARMACEUTICAL COMPOSITIONS CONTAINING ELETRIPTAN HEMISULPHATE STABILIZED WITH CAFFEINE
PL98337803A PL337803A1 (en) 1997-07-03 1998-07-01 Pharmaceutic agents containing eletriptane hemisulphate and caffeine
PT98940152T PT999841E (en) 1997-07-03 1998-07-01 PHARMACEUTICAL COMPOSITIONS CONTAINING ELETRIPTANE HEMISSULFATE
TNTNSN98126A TNSN98126A1 (en) 1997-07-03 1998-07-01 PHARMACEUTICAL COMPOSITIONS CONTAINING ELETRIPTAN HEMISULFATE
AU88569/98A AU724728B2 (en) 1997-07-03 1998-07-01 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
EA199901100A EA002174B1 (en) 1997-07-03 1998-07-01 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
CA002292673A CA2292673C (en) 1997-07-03 1998-07-01 Pharmaceutical compositions containing eletriptan hemisulphate
DE69802097T DE69802097T2 (en) 1997-07-03 1998-07-01 PHARMACEUTICAL COMPOSITIONS CONTAINING ELETRIPTANE HEMISULFATE AND CAFFEINE
HU0004468A HUP0004468A3 (en) 1997-07-03 1998-07-01 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
MA25150A MA26518A1 (en) 1997-07-03 1998-07-01 PHARMACEUTICAL COMPOSITIONS CONTAINING ELETRIPTAN HEMISULFATE
CNB988066289A CN1145486C (en) 1997-07-03 1998-07-01 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
DK98940152T DK0999841T3 (en) 1997-07-03 1998-07-01 Pharmaceuticals containing eletriptan hemisulfate and caffeine
PCT/EP1998/004176 WO1999001135A1 (en) 1997-07-03 1998-07-01 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
US09/402,239 US6166025A (en) 1997-07-03 1998-07-01 Pharmaceutical compositions containing eletriptran hemisulphate and caffeine
JP50638199A JP3350061B2 (en) 1997-07-03 1998-07-01 Pharmaceutical composition containing eletriptan hemisulfate and caffeine
KR10-1999-7012523A KR100384346B1 (en) 1997-07-03 1998-07-01 Pharmaceutical Compositions Containing Eletriptan Hemisulphate And Caffeine
BR9810658-9A BR9810658A (en) 1997-07-03 1998-07-01 Pharmaceutical compositions containing eletriptan hemisulfate and caffeine.
EP98940152A EP0999841B1 (en) 1997-07-03 1998-07-01 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
NZ501419A NZ501419A (en) 1997-07-03 1998-07-01 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine for treating migraines, depression and eating disorders
ARP980103209A AR013165A1 (en) 1997-07-03 1998-07-01 PHARMACEUTICAL COMPOSITIONS CONTAINING ELETRIPTAN HEMISULPHATE
SI9830068T SI0999841T1 (en) 1997-07-03 1998-07-01
TR1999/03332T TR199903332T2 (en) 1997-07-03 1998-07-01 Pharmaceutical compounds containing eletriptan hemissulfate and caffeine.
IL13320698A IL133206A0 (en) 1997-07-03 1998-07-01 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
ZA9805812A ZA985812B (en) 1997-07-03 1998-07-02 Pharmaceutical compositions containing eletriptan hemisulphate.
APAP/P/1998/001290A AP1100A (en) 1997-07-03 1998-07-02 Pharaceutical compositions containing eletriptan hemisulphate.
CO98037816A CO4950555A1 (en) 1997-07-03 1998-07-03 PHARMACEUTICAL COMPOSITIONS CONTAINING ELEPTRIPTAN HEMISULFATE
GT199800105A GT199800105A (en) 1997-07-03 1998-07-13 PHARMACEUTICAL COMPOSITIONS CONTAINING ELETRIPTAN HEMISULFATE.
IS5283A IS5283A (en) 1997-07-03 1999-11-30 Pharmaceutical formulations containing eletriptan hemisulfate and caffeine
BG103930A BG103930A (en) 1997-07-03 1999-11-30 Eletriptan hemisulphate and caffeine containing pharmaceutical compositions
NO19995887A NO312993B1 (en) 1997-07-03 1999-12-01 Pharmaceutical compositions containing eletripan hemisulfate and caffeine, use thereof as a medicament and for the preparation of an etheric drug
OA9900271A OA11227A (en) 1997-07-03 1999-12-03 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
HR970276A HRP990416B1 (en) 1997-07-03 1999-12-30 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
HK01100144A HK1029282A1 (en) 1997-07-03 2001-01-05 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9714081.8A GB9714081D0 (en) 1997-07-03 1997-07-03 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB9714081D0 true GB9714081D0 (en) 1997-09-10

Family

ID=10815339

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9714081.8A Pending GB9714081D0 (en) 1997-07-03 1997-07-03 Pharmaceutical compositions
GBGB9718270.3A Pending GB9718270D0 (en) 1997-07-03 1997-08-28 Pharmaceutical compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
GBGB9718270.3A Pending GB9718270D0 (en) 1997-07-03 1997-08-28 Pharmaceutical compositions

Country Status (13)

Country Link
KR (1) KR100384346B1 (en)
AP (1) AP1100A (en)
AR (1) AR013165A1 (en)
CO (1) CO4950555A1 (en)
GB (2) GB9714081D0 (en)
GT (1) GT199800105A (en)
HN (1) HN1998000101A (en)
MY (1) MY119643A (en)
PA (1) PA8454501A1 (en)
PE (1) PE84499A1 (en)
TN (1) TNSN98126A1 (en)
UA (1) UA49955C2 (en)
ZA (1) ZA985812B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
HN1998000101A (en) 1999-01-08
GB9718270D0 (en) 1997-11-05
MY119643A (en) 2005-06-30
KR100384346B1 (en) 2003-05-16
GT199800105A (en) 2000-01-04
AP1100A (en) 2002-09-02
PA8454501A1 (en) 2000-05-24
UA49955C2 (en) 2002-10-15
CO4950555A1 (en) 2000-09-01
PE84499A1 (en) 1999-09-11
KR20010014366A (en) 2001-02-26
TNSN98126A1 (en) 2005-03-15
AR013165A1 (en) 2000-12-13
ZA985812B (en) 2000-01-10
AP9801290A0 (en) 1998-09-30

Similar Documents

Publication Publication Date Title
GB9727053D0 (en) Pharmaceutical compositions
EG24118A (en) Pharmaceutical compositions
GB9706089D0 (en) Pharmaceutical composition
CY2569B1 (en) Pharmaceutical compositions
GB9616672D0 (en) Pharmaceutical compositions
GB9610359D0 (en) Pharmaceutical compositions
GB9717444D0 (en) Pharmaceutical composition
IL131995A0 (en) Gastric-retained pharmaceutical compositions
GB9723985D0 (en) Pharmaceutical compositions
GB9717428D0 (en) Pharmaceutical composition
HUP0004669A3 (en) Pharmaceutical compositions
GB9622681D0 (en) Pharmaceutical compositions
GB9606429D0 (en) Pharmaceutical compositions
HU9700632D0 (en) Pharmaceutical compositions
GB9613457D0 (en) Pharmaceutical compositions
GB9618376D0 (en) Pharmaceutical compositions
GB9717770D0 (en) Pharmaceutical composition
GB9610136D0 (en) Pharmaceutical compositions
GB9921495D0 (en) Pharmaceutical compositions
GB2321190B (en) Pharmaceutical composition
GB9726781D0 (en) Pharmaceutical composition
GB9710505D0 (en) Pharmaceutical compositions
GB9825499D0 (en) Pharmaceutical compositions
GB9725563D0 (en) Pharmaceutical compositions
GB9722066D0 (en) Pharmaceutical compositions